Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Exosomes could prove 'transformative' for hair and scalp health
1+ week, 5+ day ago (382+ words) Importantly, the researchers said all of the reviews and case series highlighted the “favourable safety profile of exosome-based therapies”. “Exosomes represent a transformative approach in trichology, offering a minimally invasive and biologically active solution for hair loss disorders,” the researchers…...
The science of Pro-V: Understanding its role in hair health
3+ mon, 1+ day ago (26+ words) The Times of India - The science of Pro-V: Understanding its role in hair health...
ABSI: ABS-201 advances in phase II trials, targeting major unmet needs in hair loss and endometriosis
3+ mon, 3+ day ago (84+ words) TradingView ABSI: ABS-201 advances in phase II trials, targeting major unmet needs in hair loss and endometriosis AI-driven drug design has enabled rapid, cost-effective development of ABS-201, now in phase II trials for androgenic alopecia and soon for endometriosis. Preclinical…...
KAIST startup Polyphenol Factory cuts hair loss by 73% with Jeju microalgae shampoo
3+ mon, 4+ day ago (556+ words) Company develops vegan PDRN hair-loss care and targets broader medical applications Hair-loss care technology using vegan PDRN (polydeoxyribonucleotide) extracted from diatoms collected in the sea off Jeju has been unveiled. In a human application test, a shampoo formulated with this…...
This New Hair-Loss Drug Could Be the Biggest Breakthrough in Decades - AOL
3+ mon, 1+ week ago (239+ words) Hair loss has been at the forefront of everyone’s mind since COVID-19. Scalp serums, hair supplements, hair-growth shampoos, massage tools, LED devices—the industry is booming. But what hasn’t necessarily caught up? Prescription options with significant data proving how they…...
This New Hair-Loss Drug Could Be the Biggest Breakthrough in Decades
3+ mon, 1+ week ago (361+ words) There’s never been an FDA-approved medication for female-pattern hair loss. Could that finally change with Veradermics? Hair loss has been at the forefront of everyone’s mind since COVID-19. Scalp serums, hair supplements, hair-growth shampoos, massage tools, LED devices—the industry…...
Scientists are seeing surprising results with this serum against hair loss
3+ mon, 3+ week ago (821+ words) The trial enrolled 60 adults in a randomized, double-blind study led by researchers in Taipei. Each participant applied one milliliter to the scalp every evening for eight weeks, while changes were tracked through standardized imaging. Initial results showed a 25% increase in…...
Veradermics Advances Pattern Hair Loss Drug Following Financial Loss
3+ mon, 3+ week ago (297+ words) Biopharmaceutical company Veradermics Inc. advanced its pipeline hair loss treatment following a reported net loss of $27.2 million for the first quarter of 2026, according to financial disclosures released on May 12. The current financial performance contrast with a net loss of $12.4 million…...
Hair Loss Treatment Could Change Forever As Scientists Grow Hair In Labs
3+ mon, 3+ week ago (405+ words) Not that long ago, people who suffered from hair loss had few options outside of donning a wig or toupee. But the hair restoration industry has come a long way and the popularity of this treatment has boomed, with an…...
SEEN Hair Care Announces Breakthrough Clinical Findings in Women's Hair Regrowth Science
3+ mon, 3+ week ago (136+ words) May 19, 2026, 09:00 ET New Study Presented at SCALE's Dermatology Meeting Demonstrates that SEEN's Non-Comedogenic, Non-Irritating Hair Care Regimen Potentiates Minoxidil 5% Foam's Efficacy, Resulting in 1.7X Increase in Non-Vellus Hair Counts, Compared to Minoxidil 5% Foam and Usual Hair Products BETHESDA, Md., May 19, 2026 /PRNewswire/ -- SEEN,…...